T FIXScrew HORIZ2a

Cutting Edge Spine Announces Notice of Issuance by the United States Patent and Trademark Office of Patent No. US 11,771,482 B2: IMPLANTS FOR TISSUE FIXATION AND FUSION

 

Orthopedic trabecular fixation screw

This patent release further strengthens Cutting Edge Spine as the market leader in the field of trabecular fixation for orthopedic applications.

MINERAL SPRINGS, NC, October 26, 2023 / OrthoSpineNews / – Cutting Edge Spine (http://www.cuttingedgespine.com), a leader in the organic development and commercialization of “passively smart” spinal technologies, today announced the Notice of issuance of the United States Patent and Trademark Office relating to Patent No. US 11,771,482 B2: IMPLANTS FOR TISSUE FIXATION AND FUSION.

This third patent issue covering trabecular screws for all orthopedic fixations gives Cutting Edge Spine an exceptionally strong position in the market compared to the transformational fixation technology offerings that are trabecular in nature.

“Our patent position gives us the opportunity to freely develop a broad portfolio of patented trabecular fixation devices for all orthopedic applications, while at the same time confidently protecting our current and future market position.” said Randy Roof-President & CEO; Founder of Cutting Edge Spine. “Our first such 510(k) cleared spine system, the T-FIX™3DSI Joint Fusion System, was introduced to the market in late spring of this year and has quickly positioned Cutting Edge Spine as a leader in the fast-growing SI sector. fixation market.”

About the advanced spine
Founded in 2009, Cutting Edge Spine (CES) is a privately held medical device organization headquartered in Mineral Springs, NC. The company is committed to developing and commercializing patented “passive smart” orthopedic technologies that are transformative relative to clinical benefit to the patient, without driving up the cost of care.

Media contact
Randy Dak
Cutting Edge Spine LLC,
1 704-839-1916
r.roof@cuttingedgespine.com, www.cuttingedgespine.com

LinkedIn

SOURCE Cutting Edge Spine, LLCrt

Source link

Similar Posts

  • 2024-2025 Rothman Orthopedic Institute Spine Research Fellowship

      This is a unique opportunity that allows candidates to work closely with Dr. Alexander R. Vaccaro, MD, PhD, MBA, Dr. Gregory D. Schroeder, MD, Dr. Christopher K. Kepler, MD, MBA, Dr. Jose Canseco, MD, PhD and the rest of the spine at the Rothman Orthopedic Institute. Dr. Alexander R. Vaccaro, MD, PhD, MBA is…

  • |

    DISC Surgery Center in Newport Beach is now enrolling patients in a clinical trial of artificial disc replacement

      Drs. Ali H. Mesiwala and Grant D. Shifflett participate in the pivotal two-level study of the safety and effectiveness of the Orthofix M6-C™ artificial cervical disc compared to anterior cervical discectomy and fusion. NEWPORT BEACH, Calif., Nov. 28, 2023 /PRNewswire/ – DISC Surgery Center of Newport Beach (“DISC”), committed to supporting research vital to…

  • |

    DVT after knee surgery

    What if the biggest threat to your recovery isn’t the orthopedic procedure itself, but a silent complication that can strike without warning? Deep vein thrombosis is a serious medical concern. It affects approximately 600,000 Americans each year. We recognize that undergoing a major joint operation requires careful attention to potential complications. DVT after knee surgery prevention Our goal is to provide a clear guide on managing this specific risk. Understanding how a dangerous clot forms in the leg is the vital first step. This knowledge empowers you during the post-operative period. We emphasize that proactive management of your health is essential. By following expert-led advice, you can take control. This effort minimizes chances of a serious vascular issue and supports a smoother healing journey. Key Takeaways Deep vein thrombosis is a common but serious risk following major orthopedic procedures. Proactive health management is crucial for a safe post-operative period. Understanding how blood clots form is the first step in prevention. Expert guidance can help you minimize dangers and take control of your healing process. A smooth recovery involves being aware of potential complications from the start. Simple, informed actions can significantly reduce your personal risk. Understanding the Risk of DVT After Knee Surgery Why does a procedure focused on improving mobility simultaneously increase the chance of a dangerous blockage? We must explore the nature of the threat and the specific factors a major operation introduces. What is Deep Vein Thrombosis? This condition involves a blood clot forming in a deep vein, usually in the leg. If such a clot breaks free, it can travel to the lungs. This causes a life-threatening pulmonary embolism. We note that approximately 600,000 Americans are affected each year. It is a critical concern following any major joint replacement. deep vein thrombosis risk factors Why Knee Surgery Increases the Clot Risk Several factors converge during a knee replacement. The body’s natural healing response can make blood more likely to clot. Reduced mobility after the procedure slows circulation in the legs. The risk is highest from two to ten days post-operation. Patients remain at risk for about three months. Without preventative care, studies show blood clot rates of 40-60%. Even with modern care, 18-20% of joint replacement patients may still develop a clot. This highlights the need to watch for swelling in the leg. Timeframe Risk Level Key Data Initial High-Risk Period Highest 2 to 10 days after surgery Extended Risk Period Elevated Up to 3 months post-operation Without Prevention Very High 40-60% clot rate in major orthopedic surgery With Modern Protocols Significant 18-20% of knee replacement patients Prevention and Treatment Approaches Managing the threat of post-operative clots involves a dual strategy of medication and mechanical aids. We focus on keeping your circulation strong during the healing phase. This two-part defense significantly lowers your personal danger. Medication and Anti-Clotting Therapies We often prescribe specific drugs to reduce your body’s ability to form dangerous masses. Options include injections like Heparin or daily pills such as Warfarin. Newer direct oral anticoagulants offer convenient pill-based therapy. Your doctor selects the best type based on your health profile. anti clotting medication and compression…

  • |

    POLARIS AR receives US Food and Drug Administration approval for STELLAR Knee

      MIAMI, Nov. 3, 2023 /PRNewswire/ — POLARISAR is pleased to announce today that their STELLAR knee has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). STELLAR Knee is the first approval for POLARISARa company focused on creating a new category in surgical guidance in Mixed Reality. POLARISAR and STELLAR Knee are…

  • SECRE technology paves the way for new therapies for autoimmune diseases

    Scientists have developed a potentially transformative new technique that could help in the discovery and development of new therapies for a number of globally prevalent autoimmune diseases. Conditions such as lupus, rheumatoid arthritis and inflammatory bowel disease (IBD) – as well as malfunctions in transplanted cells – are all caused by altered cytokine secretion from…

2 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *